iFGF23:cFGF23 ratio as a new diagnostic and prognostic marker in acute kidney injury.
2017/27/N/NZ5/02504
Keywords
Descriptors
- NZ5_5: Diagnostyka chorób człowieka
- NZ5_3: Patogeneza chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim
Voivodeship: podlaskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 14 – announced on 2017-09-15
- Amount awarded
- 210 000 PLN
- Project start date
- 2018-08-27
- Project end date
- 2024-08-26
- Project duration
- 72 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
iFGF23:cFGF23 Ratio Is a Questionable Diagnostic Marker for Distinguishing Between Acute and Chronic Kidney Disease
- Authors:
- Joanna Szczykowska-Miller, Tomasz Hryszko, Ewa Koc-Zórawska and Beata Naumnik
- Academic press:
- International Journal of Molecular Sciences (year: 2025, volume: 26, pages: 7952), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms26167952 – link to the publication